Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
Agreement enables procurement in over 50 countries
Original title: “ViiV and Axmed expand access to HIV medicines”
systematic review of clinical trials and cohort studies evaluating hiv post exposure prophylaxis pep regimens to inform updated canadian guidelines
Original title: “Systematic review of clinical trials and cohort studies evaluating HIV post-exposure prophylaxis (PEP) regimens to inform updated Canadian guidelines.”
gaps in diabetes care among people living with hiv and hypertension in botswana a cross sectional analysis of the intercare study
Original title: “Gaps in diabetes care among people living with HIV and hypertension in Botswana: A cross-sectional analysis of the InterCARE study.”
encleistoids a m c ring aromatized ent cleistanthane diterpenoids with anti hiv activity from two phyllanthaceae species
Original title: “Encleistoids A-M, C-ring aromatized ent-cleistanthane diterpenoids with anti-HIV activity from two Phyllanthaceae species.”
hiv breakthrough infection after 6 years of daily tdf ftc oral prep with objectively documented optimal adherence
Original title: “HIV breakthrough infection after 6 years of daily TDF/FTC oral PrEP with objectively documented optimal adherence.”
acute autoimmune hepatitis diagnosed concurrently with human immunodeficiency virus
Original title: “Acute autoimmune hepatitis diagnosed concurrently with human immunodeficiency virus.”
esophageal tuberculosis mimicking a neoplasm in a patient with hiv infection
Original title: “Esophageal tuberculosis mimicking a neoplasm in a patient with HIV infection.”
aspergillus tubingensis pneumonia with pulmonary oxalosis in a virologically suppressed person with hiv a case report
Original title: “Aspergillus tubingensis Pneumonia with Pulmonary Oxalosis in a Virologically Suppressed Person with HIV: A Case Report.”
lenacapavir resistance surveillance in full length hiv 1 proviral dna and circulating rna major rams are rare and absent in intact proviral dna
Original title: “Lenacapavir resistance surveillance in full-length HIV-1 proviral DNA and circulating RNA: Major RAMs are rare and absent in intact proviral DNA.”
gastric adenosquamous carcinoma with an apparently pure squamous phenotype on limited biopsy in a patient with hiv a case report
Original title: “Gastric adenosquamous carcinoma with an apparently pure squamous phenotype on limited biopsy in a patient with HIV: A case report.”
evaluating an anti idiotype derived germline targeting immunogen designed to elicit vrc01 class precursors in human antibody transgenic mice
Original title: “Evaluating an anti-idiotype derived germline-targeting immunogen designed to elicit VRC01-class precursors in human antibody transgenic mice.”
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $750,000 for Federal Fiscal Year 2026 funding to Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), subject to the availability of funds. The award supports activities to improve HIV care and treatment for children and eliminate mother-to-child HIV transmission faster, working with faith-based organizations (FBOs), faith-affiliated health f
Original title: “Notice of Award of a Single Source Cooperative Agreement To Fund Elizabeth Glaser Pediatric AIDS Foundation”
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $15,000,000 for Federal Fiscal Year 2026 funding to Ministry of Health Zambia, subject to the availability of funds. Funding amounts for years 2-5 will be set at continuation. The award will support Zambia through the Ministry of Health (MOH) to lead and oversee the national HIV response in alignment with the U.S. Government's (USG) goal to
Original title: “Notice of Award of a Sole Source Cooperative Agreement To Fund Ministry of Health Zambia”
global regional and national burden of hiv aids 1990 2023 with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030 results from the global burden of disease study 2023
Original title: “Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.”
immunophenotype and proviral landscape of hiv infected cd4 t cells during antiretroviral therapy
Original title: “The immunophenotype and proviral landscape of HIV-infected CD4 T cells during antiretroviral therapy.”
switching from tenofovir disoproxil fumarate to bictegravir emtricitabine tenofovir alafenamide or non tenofovir alafenamide regimens a real world study of safety and efficacy in chinese people living with hiv
Original title: “Switching from tenofovir disoproxil fumarate to bictegravir/emtricitabine/ tenofovir alafenamide or non-tenofovir alafenamide regimens: a real-world study of safety and efficacy in Chinese people living with HIV.”
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $30,000,000, for Federal Fiscal Year 2026 funding to the Ministry of Health (MOH), subject to the availability of funds. Funding amounts for years 2-5 will be set at continuation. The award is expected to help build and oversee national HIV and TB programs in Ethiopia through the MOH and its affiliates.
Original title: “Notice of Award of a Sole Source Cooperative Agreement To Fund the Ministry of Health of Ethiopia”
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $30,000,000, for Federal Fiscal Year 2026 funding to Zambia's University Teaching Hospital (UTH), subject to availability of funds. Funding amounts for years 2-5 will be set at continuation. The award is expected to improve HIV and TB clinical and laboratory service delivery at referral level hospitals and provincial- level referral faciliti
Original title: “Notice of Award of a Sole Source Cooperative Agreement To Fund University Teaching Hospital in Zambia”
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $15,000,000, for Federal Fiscal Year 2026 funding to Public Health Center (PHC) of the Ministry of Health of Ukraine, subject to the availability of funds. Funding amounts for years 2-5 will be set at continuation. The award is expected to advance HIV and TB epidemic control in Ukraine with activities to include enhancing integrated HIV serv
Original title: “Notice of Award of a Sole Source Cooperative Agreement To Fund Public Health Center of the Ministry of Health of Ukraine”
bilateral pathological femoral fractures secondary to long term tenofovir disoproxil fumarate induced osteomalacia in a woman living with hiv a case report
Original title: “Bilateral Pathological Femoral Fractures Secondary to Long-Term Tenofovir Disoproxil Fumarate-Induced Osteomalacia in a Woman Living with HIV: A Case Report.”